# A Study of AAV-hAADC-2 in Subjects With Parkinson's Disease

> **NCT00229736** · PHASE1 · COMPLETED · sponsor: **Genzyme, a Sanofi Company** · enrollment: 10 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **GENETIC:** AAV-hAADC-2
- **GENETIC:** AAV-hAADC-2

## Key facts

- **NCT ID:** NCT00229736
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2013-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00229736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00229736, "A Study of AAV-hAADC-2 in Subjects With Parkinson's Disease". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00229736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*